Additionally, the potential contribution of rs16260-A allele to GC risk remains controversial [ 23 , 24 ], while the potential prognostic value of this variant in breast cancer and in metastatic colon cancer did not reach statistical significance [ 25 , 26 ].
← all excerpts
Characterizing Metastatic <i>HER2</i>-Positive Gastric Cancer at the <i>CDH1</i> Haplotype.
1
—
—